<?xml version='1.0' encoding='UTF-8'?>
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="publisher-id">nss</journal-id>
      <journal-title-group>
        <journal-title>Nature and Science of Sleep</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1179-1608</issn>
      <publisher>
        <publisher-name>Dove</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">35264890</article-id>
      <article-id pub-id-type="pmc">8901229</article-id>
      <article-id pub-id-type="publisher-id">343205</article-id>
      <article-id pub-id-type="doi">10.2147/NSS.S343205</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Combined Association Between <italic toggle="yes">ADIPOQ, PPARG</italic>, and <italic toggle="yes">TNF</italic> Genes Variants and Obstructive Sleep Apnea in Chinese Han Population</article-title>
        <alt-title alt-title-type="running-authors">Li et al</alt-title>
        <alt-title alt-title-type="running-title">Li et al</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Juan</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lv</surname>
            <given-names>Qianwen</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6556-9922</contrib-id>
          <name>
            <surname>Sun</surname>
            <given-names>Haili</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Yunyun</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jiao</surname>
            <given-names>Xiaolu</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Song</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>Huahui</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5185-9726</contrib-id>
          <name>
            <surname>Qin</surname>
            <given-names>Yanwen</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref>
          <xref rid="an0001" ref-type="corresp"/>
        </contrib>
        <aff id="aff0001"><label>1</label><institution>Key Laboratory of Upper Airway Dysfunction-Related Cardiovascular Diseases, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung, and Blood Vessel Diseases</institution>, <addr-line>Beijing</addr-line>, <addr-line>100029</addr-line>, <country>People’s Republic of China</country></aff>
        <aff id="aff0002"><label>2</label><institution>Emergency Department, Beijing Shijitan Hospital, Capital Medical University</institution>, <addr-line>Beijing</addr-line>, <addr-line>100038</addr-line>, <country>People’s Republic of China</country></aff>
        <aff id="aff0003"><label>3</label><institution>Key Laboratory of Remodeling-related Cardiovascular Diseases, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases</institution>, <addr-line>Beijing</addr-line>, <addr-line>100029</addr-line>, <country>People’s Republic of China</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="an0001">Correspondence: Yanwen Qin, <institution>Key Laboratory of Upper Airway Dysfunction-Related Cardiovascular Diseases, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases</institution>, <addr-line>No. 2 Anzhen Road, Chaoyang District</addr-line>, <addr-line>Beijing</addr-line>, <addr-line>100029</addr-line>, <country>People’s Republic of China</country>, <phone>Tel +86-10-64456529</phone>, <fax>Fax +86-10-64456095</fax>, Email qinyanwen@vip.126.com; qinyanwen@ccmu.edu.cn</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>03</day>
        <month>3</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2022</year>
      </pub-date>
      <volume>14</volume>
      <fpage>363</fpage>
      <lpage>372</lpage>
      <history>
        <date date-type="received">
          <day>07</day>
          <month>10</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>09</day>
          <month>2</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2022 Li et al.</copyright-statement>
        <copyright-year>2022</copyright-year>
        <copyright-holder>Li et al.</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref>
          <license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <sec id="s2001">
          <title>Purpose</title>
          <p><citation_analysis attribute="negative">Obstructive sleep apnea (OSA) is a common chronic polygenic disease. Multiple genetic markers associated with OSA have been identified by genome-wide association studies. Here, we aimed to construct a polygenic risk score (PRS) and examine the association with the presence of OSA in a Chinese Han Population.</citation_analysis></p>
        </sec>
        <sec id="s2002">
          <title>Patients and Methods</title>
          <p><citation_analysis attribute="positive">This study included 1057 individuals who were genotyped for nine susceptibility loci from three genes (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">ADIPOQ, PPARG</italic></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">TNF</italic></citation_analysis><citation_analysis attribute="positive">), from which each individual’s PRS was calculated by summing the number of risk alleles. The associations between PRS and OSA were determined by logistic regression analyses. Model discrimination was assessed by a receiver operating characteristic (ROC) curve using bootstrapping with 1000 resamples.</citation_analysis></p>
        </sec>
        <sec id="s2003">
          <title>Results</title>
          <p><citation_analysis attribute="positive">The subjects included 874 with OSA and 183 controls. A higher PRS was associated with an increased apnea-hypopnea index (AHI). The PRS was an important risk factor for the development of OSA (OR = 1.237 per SD, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.030). Subjects with higher PRS had a 2.88-fold (95% CI: 1.393–5.955, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.004) and 5.402-fold (95% CI: 2.311–12.624, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="negative">&lt;0.001) greater risk for having OSA and moderate-to-severe OSA, respectively, compared with those with lower genetic risk. More importantly, compared with determination of risk based solely on clinical factors, addition of the PRS increased discriminatory accuracy for both OSA (AUC from 0.75 to 0.78, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.02) and moderate-to-severe OSA (AUC from 0.80 to 0.83, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.02).</citation_analysis></p>
        </sec>
        <sec id="s2004">
          <title>Conclusion</title>
          <p><citation_analysis attribute="negative">Our study suggests that the PRS is independently associated with AHI and OSA. Combining PRS with conventional risk factors could improve the discrimination of OSA.</citation_analysis></p>
        </sec>
      </abstract>
      <kwd-group kwd-group-type="author">
        <title>Keywords</title>
        <kwd>polygenic risk score</kwd>
        <kwd>apnea-hypopnea index</kwd>
        <kwd>single nucleotide polymorphisms</kwd>
        <kwd>discriminatory accuracy</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
<institution-wrap><institution>National Natural Science Foundation of China</institution><institution-id institution-id-type="open-funder-registry">10.13039/501100001809</institution-id></institution-wrap>
</funding-source>
        </award-group>
        <award-group>
          <funding-source>
<institution-wrap><institution>the Beijing Natural Science Foundation</institution></institution-wrap>
</funding-source>
        </award-group>
        <award-group>
          <funding-source>
<institution-wrap><institution>Beijing Key Laboratory of Upper Airway Dysfunction and Related Cardiovascular Diseases</institution></institution-wrap>
</funding-source>
        </award-group>
        <funding-statement>This study was supported by the National Natural Science Foundation of China (Grant Nos. 81670331, 81970224, and 81870335) and the Beijing Natural Science Foundation (Grant No. 7192030) Beijing Key Laboratory of Upper Airway Dysfunction and Related Cardiovascular Diseases (No: BZ0377).</funding-statement>
      </funding-group>
      <counts>
        <fig-count count="2"/>
        <table-count count="9"/>
        <ref-count count="31"/>
        <page-count count="10"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s0001">
      <title>Introduction</title>
      <p><citation_analysis attribute="neither">Obstructive sleep apnea (OSA) is a common sleep disorder caused by blockage of the Upper Airway.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither"> Patients with OSA experience recurrent episodes of intermittent hypoxia and hypercapnia during sleep.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0002" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="neither"> Although 34% of men and 17% of women are estimated to be affected by this disease, the majority of OSA patients remain largely undiagnosed.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0003" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="negative"> Moreover, OSA itself has been recognized as a risk factor for cardiovascular disease, metabolic dysregulation, cancer, and all-cause death.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0004" ref-type="bibr">4</xref></citation_analysis><citation_analysis attribute="neither"> OSA is a complex disorder involving multiple factors, including hereditary and environmental components.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0005" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="positive"> There is growing evidence that genetic factors and their interactions with the environment can influence the development of OSA. Indeed, most cases of OSA do not exhibit classical Mendelian patterns of inheritance, suggesting that multiple genes are involved in its pathogenesis.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0006" ref-type="bibr">6</xref></citation_analysis></p>
      <p><citation_analysis attribute="negative">Obesity, especially abdominal obesity, is a major risk factor for OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0007" ref-type="bibr">7</xref></citation_analysis><citation_analysis attribute="neither"> In obese patients, adipocytes secrete a variety of adipokines and inflammatory factors, such as adiponectin (ADIPOQ), peroxisome proliferator-activated receptor gamma (PPARG), and tumor necrosis factor (TNF). These factors play an important role in the occurrence and progression of OSA, as well as in the development of related complications.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0008" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0009" ref-type="bibr">9</xref></citation_analysis><citation_analysis attribute="positive"> There is evidence of both direct genetic contributions to OSA susceptibility and indirect contributions such as obesity, craniofacial structure, neurological control of upper airway muscles and of sleep and circadian rhythm. Thus, common polymorphisms in genes involved in obesity are possible good candidates for predicting OSA susceptibility.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Most studies on OSA genetics have focused on single genes. A genome-wide approach may provide greater information, beyond that of individual candidate genes. However, data from such studies are limited at present. We previously showed that </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">ADIPOQ</italic></citation_analysis><citation_analysis attribute="neither"> variants rs3774262, rs4686803, rs1063537, rs2082940, and the </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">PPARG</italic></citation_analysis><citation_analysis attribute="neither"> variant rs1801282 were associated with the prevalence of OSA in Han Chinese individuals.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0010" ref-type="bibr">10</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0011" ref-type="bibr">11</xref></citation_analysis><citation_analysis attribute="neither"> Using the same dataset, we also found that single nucleotide polymorphisms (SNPs) rs3093661, rs3093662, and rs3093664 in the </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">TNF</italic></citation_analysis><citation_analysis attribute="negative"> gene were associated with increased risk of OSA (</citation_analysis><citation_analysis attribute="positive"><underline><ext-link xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=343205.docx" ext-link-type="uri">Supplemental Table 1</ext-link></underline></citation_analysis><citation_analysis attribute="neither">).</citation_analysis></p>
      <p><citation_analysis attribute="negative">Polygenic risk scores (PRS), which consider multiple SNPs associated with diseases, have been widely studied in many conditions, such as coronary heart disease, cancer, and type 2 diabetes. However, it has not yet been applied to OSA disease. Therefore, we combined nine SNPs from </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">ADIPOQ, PPARG</italic></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">TNF</italic></citation_analysis><citation_analysis attribute="positive"> genes into a PRS, then determined the effects of the PRS on apnea-hypopnea index (AHI) and the risk of OSA in 1057 individuals.</citation_analysis></p>
    </sec>
    <sec id="s0002">
      <title>Methods</title>
      <sec id="s0002-s2001">
        <title>Study Participants</title>
        <p><citation_analysis attribute="positive">Subjects included in this study were Chinese individuals who visited the Beijing An Zhen Hospital because of snoring or sleep apnea from April 2017 to January 2019. All participants received an overnight polysomnography (PSG), which was conducted using a level II portable diagnostic device (SOMNOscreen; SOMNOmedics GmbH, Randersacker, Germany) approved by the US Food and Drug Administration. This included nasal pressure sensors, thermistors, thoracoabdominal belts, blood oxygen probes, and snoring sensors to monitor breathing, as described in our first study.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0012" ref-type="bibr">12</xref></citation_analysis><citation_analysis attribute="neither"> Ventilatory flow at the nose and mouth was measured with thermistors. Ventilatory movements of the chest and abdomen were monitored by inductive plethysmography bands. The arterial oxygen saturation (SpO2) was measured transcutaneously with fingertip pulse oximetry. We applied the scoring guidelines and sleep apnea definition of the American Academy of Sleep Medicine. A respiratory event was scored as an apnea in adults if complete cessation of airflow occurred for ≥ 10s. Hypopnea was defined as respiratory airflow reduced by 30% with a 4% decrease in oxygen saturation. Apnea events were classified as obstructive, mixed, or central according to the presence or absence of breathing efforts with thoracoabdominal paradox. The AHI was determined by dividing the total number of apnea/hypopnea events by the estimated hours of sleep. OSA patients and non-OSA subjects were confirmed on the basis of American Academy of Sleep Medicine Guidelines.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0013" ref-type="bibr">13</xref></citation_analysis><citation_analysis attribute="positive"> OSA was defined as those subjects with an AHI ≥ 5 per hour. Subjects with an AHI &lt; 5 served as controls. OSA severity was quantified via the AHI: mild OSA (AHI: 5–14.9), moderate OSA (AHI: 15–29.9), or severe OSA (AHI ≥ 30). The criteria for exclusion from the study included: (1) the presence of other sleep disorders or a history of treatment for sleep-related breathing disorders; (2) the presence of other diseases, such as congestive heart failure, cancer, acute infectious disease, hepatic dysfunction, or abnormal renal function; and (3) pregnancy. In total, 1057 subjects were included in the study (the study flow chart is shown in </citation_analysis><citation_analysis attribute="positive"><underline><ext-link xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=343205.docx" ext-link-type="uri">Supplementary Figure 1</ext-link></underline></citation_analysis><citation_analysis attribute="neither">), and all participants provided written informed consent. The study was approved by the Medicine Ethics Committee of Beijing An Zhen Hospital (2017005) and was registered in the Chinese Clinical Trial Register (ChiCTR-ROC-17011027).</citation_analysis></p>
      </sec>
      <sec id="s0002-s2002">
        <title>Data Collection</title>
        <p><citation_analysis attribute="positive">Demographic data, including age, gender, height, body weight, smoking status, drinking status, and current medication usage, were collected using questionnaires and medical histories. Participants also completed the Berlin questionnaire (BQ) and the Epworth Sleepiness Scale questionnaire. Patients were considered high risk for OSA if they scored positive in two or more categories of the BQs,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0014" ref-type="bibr">14</xref></citation_analysis><citation_analysis attribute="neither"> while the remaining individuals were considered low risk. Subjects were classified as nonsmokers if they had never smoked or had stopped smoking ≥ 1 year before enrollment in the study; all other subjects were classified as smokers. Subjects were defined as drinkers if they drink ≥ 3 times a week. Obesity was defined as a body mass index (BMI) ≥ 28 kg/m</citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="neither">, according to the recommendations of the Health Promotion Administration.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0015" ref-type="bibr">15</xref></citation_analysis><citation_analysis attribute="neither"> Blood samples were taken after 8–12 h of fasting from each subject and centrifuged at 2943 × g at 4°C for 10 min. Half the sample was used for DNA isolation, while the remaining half was used to obtain serum for biochemical analysis. Genomic DNA was extracted from 200 μL of blood according to the protocol provided in the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany). Fasting plasma glucose (FPG) levels and a fasting lipid profile, including the levels of high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), and triglycerides (TGs), were measured according to standard laboratory methods at Beijing An Zhen Hospital.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2003">
        <title>Genotyping and Calculation of PRS</title>
        <p><citation_analysis attribute="positive">We selected nine SNPs for the PRS from obesity-related genes, which had reported strong associations with OSA based on the literature and our previous work. These nine SNPs in three genes (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">ADIPOQ</italic></citation_analysis><citation_analysis attribute="neither"> rs1063537, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">ADIPOQ</italic></citation_analysis><citation_analysis attribute="neither"> rs2082940, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">ADIPOQ</italic></citation_analysis><citation_analysis attribute="neither"> rs4686803, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">ADIPOQ</italic></citation_analysis><citation_analysis attribute="neither"> rs2241766, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">ADIPOQ</italic></citation_analysis><citation_analysis attribute="neither"> rs3774262, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">TNF</italic></citation_analysis><citation_analysis attribute="neither"> rs3093661, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">TNF</italic></citation_analysis><citation_analysis attribute="neither"> rs3093662, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">TNF</italic></citation_analysis><citation_analysis attribute="neither"> rs3093664, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">PPARG</italic></citation_analysis><citation_analysis attribute="positive"> rs1801282) chosen for this study were genotyped using Agena MassARRAY (Agena Bioscience, San Diego, CA, USA) following the manufacturer’s protocol. Assay Designer version 4.0 was used in accordance with the manufacturer’s guide to determine the specific PCR primer and extension primer sequences (</citation_analysis><citation_analysis attribute="positive"><underline><ext-link xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=343205.docx" ext-link-type="uri">Supplemental Table 2</ext-link></underline></citation_analysis><citation_analysis attribute="neither">). Agena Typer 4.0 software was used for data management and analysis. SNPs with </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither">-values for the test of deviation from the Hardy–Weinberg equilibrium of 0.05 were excluded for further analysis.</citation_analysis></p>
        <p><citation_analysis attribute="negative">Individuals homozygous for non-risk alleles were given a score of 0, heterozygotes were given a score of 1, and individuals homozygous for risk alleles were given a score of 2. The PRS was constructed by summing the number of risk alleles among the nine gene variants in each individual.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2004">
        <title>Statistical Analyses</title>
        <p><citation_analysis attribute="positive">Continuous variables are expressed as the mean ± standard deviation or median (interquartile range), and categorical variables are expressed as a number (percentage). Differences in the distribution of risk factor data between OSA and controls were assessed using a two-sided </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">χ</italic></citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="neither"> test or a Student’s </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">t</italic></citation_analysis><citation_analysis attribute="neither">-test, where appropriate. Each allele-specific odds ratio (OR) with 95% confidence intervals (CIs) and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="positive">-values for OSA were calculated under the assumption of an additive model using logistic regression analysis, adjusting for age, sex, BMI, systolic blood pressure (SBP), diastolic blood pressure (DBP), TG, FPG, and smoking status. Association between the PRS and AHI was tested with linear regression. The risk of OSA associated with the 9-SNP PRS was calculated continuously. This was done with the addition of one risk allele. Then, after stratification into low risk (≤ 20th percentile), intermediate risk (20th–80th percentile), and high risk score (≥ 80th percentile) categories by calculating ORs, it was adjusted for clinical risk factors. Univariate and multivariate logistic regression analysis was performed to identify variables (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="positive"> &lt; 0.05) that significantly affected OSA. We then estimated the area under the receiver operating characteristic (ROC) curve (AUC) for risk scores that included clinical risk factors alone, the PRS alone, and the two combined. To compare the AUC of two models, we calculated the Wald statistic by dividing the observed difference of AUC estimates of the two models by the standard error of the difference obtained from bootstrapping. The model was validated internally using bootstrapping with 1000 resamples. We considered a two-sided </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="positive">-value &lt; 0.05 as statistically significant. Analyses were carried out using SPSS 23.0 (IBM Corp., Armonk, NY, USA) and EmpowerStats software (</citation_analysis><citation_analysis attribute="positive"><underline><ext-link xlink:href="http://www.empowerstats.com" ext-link-type="uri">www.empowerstats.com</ext-link></underline></citation_analysis><citation_analysis attribute="neither">, X&amp;Y solutions, Inc., Boston, MA, USA).</citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0003">
      <title>Results</title>
      <sec id="s0003-s2001">
        <title>Physical and Clinical Characteristics of Study Subjects</title>
        <p><citation_analysis attribute="positive">We evaluated a total of 1057 Chinese subjects, including 874 with OSA and 183 controls. Their physical and clinical characteristics are presented in </citation_analysis><citation_analysis attribute="positive"><xref rid="t0001" ref-type="table">Table 1</xref></citation_analysis><citation_analysis attribute="neither">. In brief, individuals with OSA had a higher average BMI (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001) than the controls, and those with OSA were older than the controls (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.026). There were more males (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001) in the OSA group compared with the controls. OSA patients tended to have higher levels of TG (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001). HDL-C levels (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.584), LDL-C levels (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.928), and TC levels (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="positive"> = 0.532) showed no significant differences between the two groups. Blood pressure measurements in control subjects were significantly different from those of OSA patients (all </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="positive"> &lt; 0.05). The OSA patient group tended to have more smokers than the control group, but the difference was not statistically significant (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.066).</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0001"><label>Table 1</label><caption><p><citation_analysis attribute="neither">Characteristics of Participants</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">N</th><th rowspan="1" colspan="1">Control</th><th rowspan="1" colspan="1">OSA</th><th rowspan="2" colspan="1">P</th></tr><tr><th rowspan="1" colspan="1">183</th><th rowspan="1" colspan="1">874</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age (years)</td><td rowspan="1" colspan="1">50.4 ± 14.3</td><td rowspan="1" colspan="1">52.7 ± 12.2</td><td rowspan="1" colspan="1">0.026*</td></tr><tr><td rowspan="1" colspan="1">Male (n, %)</td><td rowspan="1" colspan="1">123 (67.2%)</td><td rowspan="1" colspan="1">738 (84.4%)</td><td rowspan="1" colspan="1">&lt;0.001**</td></tr><tr><td rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1">24.6 ± 3.9</td><td rowspan="1" colspan="1">27.8 ± 3.9</td><td rowspan="1" colspan="1">&lt;0.001**</td></tr><tr><td rowspan="1" colspan="1">SBP (mmHg)</td><td rowspan="1" colspan="1">126.9 ± 19.7</td><td rowspan="1" colspan="1">131.2 ± 18.7</td><td rowspan="1" colspan="1">0.005*</td></tr><tr><td rowspan="1" colspan="1">DBP (mmHg)</td><td rowspan="1" colspan="1">78.0 ± 14.3</td><td rowspan="1" colspan="1">81.5 ± 14.0</td><td rowspan="1" colspan="1">0.003*</td></tr><tr><td rowspan="1" colspan="1">HDL-C(mmol/L)</td><td rowspan="1" colspan="1">1.2 ± 0.3</td><td rowspan="1" colspan="1">1.2 ± 0.8</td><td rowspan="1" colspan="1">0.584</td></tr><tr><td rowspan="1" colspan="1">LDL-C(mmol/L)</td><td rowspan="1" colspan="1">2.7 ± 0.8</td><td rowspan="1" colspan="1">2.7 ± 1.0</td><td rowspan="1" colspan="1">0.928</td></tr><tr><td rowspan="1" colspan="1">TC (mmol/L)</td><td rowspan="1" colspan="1">4.5 ± 1.1</td><td rowspan="1" colspan="1">4.6 ± 2.3</td><td rowspan="1" colspan="1">0.532</td></tr><tr><td rowspan="1" colspan="1">TG#(mmol/L)</td><td rowspan="1" colspan="1">1.29 (0.95–1.72)</td><td rowspan="1" colspan="1">1.62 (1.13–2.31)</td><td rowspan="1" colspan="1">&lt;0.001**</td></tr><tr><td rowspan="1" colspan="1">FPG (mmol/L)</td><td rowspan="1" colspan="1">5.4 ± 1.7</td><td rowspan="1" colspan="1">6.6 ± 20.4</td><td rowspan="1" colspan="1">0.405</td></tr><tr><td rowspan="1" colspan="1">Drinker (n, %)</td><td rowspan="1" colspan="1">71 (38.8%)</td><td rowspan="1" colspan="1">372 (42.6%)</td><td rowspan="1" colspan="1">0.342</td></tr><tr><td rowspan="1" colspan="1">Smoker (n, %)</td><td rowspan="1" colspan="1">70 (38.3%)</td><td rowspan="1" colspan="1">397 (45.7%)</td><td rowspan="1" colspan="1">0.066</td></tr><tr><td rowspan="1" colspan="1">AHI (times/h)</td><td rowspan="1" colspan="1">2.3 (1.3–3.4)</td><td rowspan="1" colspan="1">22.9 (12.4–40.1)</td><td rowspan="1" colspan="1">&lt;0.001**</td></tr><tr><td rowspan="1" colspan="1">ESS score#</td><td rowspan="1" colspan="1">6 (3–10)</td><td rowspan="1" colspan="1">7(4–12)</td><td rowspan="1" colspan="1">&lt;0.001**</td></tr><tr><td rowspan="1" colspan="1">Berlin Questionnaire high risk (n, %)</td><td rowspan="1" colspan="1">35 (27.78%)</td><td rowspan="1" colspan="1">458 (56.68%)</td><td rowspan="1" colspan="1">&lt;0.001**</td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="neither">: Values were expressed as mean ± standard deviation, median ± interquartile range or n (%). #Data were asymmetrically distributed and expressed as median ± interquartile. Differences between groups were analyzed by independent Student’s </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">t</italic></citation_analysis><citation_analysis attribute="neither">-test, Fisher’s exact test, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">χ</italic></citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="neither"> test, or Wilcoxon test. *P&lt;0.05, **P&lt;0.001.</citation_analysis></p></fn><fn id="tfn0002"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="neither">: OSA, obstructive sleep apnea; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; TG, triglycerides; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; AHI, apnea-hypopnea index; ESS, Epworth Sleepiness Scale.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
      </sec>
      <sec id="s0003-s2002">
        <title>Association of PRS with AHI and OSA</title>
        <p><citation_analysis attribute="neither">The genotype distributions of these nine SNPs were all in Hardy-Weinberg equilibrium (</citation_analysis><citation_analysis attribute="positive"><underline><ext-link xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=343205.docx" ext-link-type="uri">Supplemental Table 3</ext-link></underline></citation_analysis><citation_analysis attribute="positive">). The associations of each of the nine SNPs with OSA are shown in </citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="positive">. When analyzed individually, each SNP showed little or no significant association with OSA.</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0002"><label>Table 2</label><caption><p><citation_analysis attribute="neither">Individual Effects of 9 Risk Alleles of the Susceptibility Loci on OSA</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">SNP</th><th rowspan="1" colspan="1">Risk Allele</th><th rowspan="1" colspan="1">OR (95% CI)</th><th rowspan="1" colspan="1">P</th><th rowspan="1" colspan="1">FDR</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><italic toggle="yes">ADIPOQ</italic></td><td rowspan="1" colspan="1">rs1063537</td><td rowspan="1" colspan="1">T</td><td rowspan="1" colspan="1">1.305(0.959–1.776)</td><td rowspan="1" colspan="1">0.091</td><td rowspan="1" colspan="1">0.0278</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">ADIPOQ</italic></td><td rowspan="1" colspan="1">rs2082940</td><td rowspan="1" colspan="1">T</td><td rowspan="1" colspan="1">1.284(0.945–1.744)</td><td rowspan="1" colspan="1">0.110</td><td rowspan="1" colspan="1">0.0333</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">ADIPOQ</italic></td><td rowspan="1" colspan="1">rs4686803</td><td rowspan="1" colspan="1">T</td><td rowspan="1" colspan="1">1.335(0.981–1.817)</td><td rowspan="1" colspan="1">0.066</td><td rowspan="1" colspan="1">0.0167</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">ADIPOQ</italic></td><td rowspan="1" colspan="1">rs2241766</td><td rowspan="1" colspan="1">G</td><td rowspan="1" colspan="1">1.342(0.985–1.827)</td><td rowspan="1" colspan="1">0.062</td><td rowspan="1" colspan="1">0.0111</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">ADIPOQ</italic></td><td rowspan="1" colspan="1">rs3774262</td><td rowspan="1" colspan="1">A</td><td rowspan="1" colspan="1">1.329(0.976–1.811)</td><td rowspan="1" colspan="1">0.071</td><td rowspan="1" colspan="1">0.0222</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">TNF</italic></td><td rowspan="1" colspan="1">rs3093661</td><td rowspan="1" colspan="1">A</td><td rowspan="1" colspan="1">1.394(0.685–2.837)</td><td rowspan="1" colspan="1">0.359</td><td rowspan="1" colspan="1">0.05</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">TNF</italic></td><td rowspan="1" colspan="1">rs3093662</td><td rowspan="1" colspan="1">G</td><td rowspan="1" colspan="1">1.493(0.735–3.030)</td><td rowspan="1" colspan="1">0.268</td><td rowspan="1" colspan="1">0.0389</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">TNF</italic></td><td rowspan="1" colspan="1">rs3093664</td><td rowspan="1" colspan="1">G</td><td rowspan="1" colspan="1">1.442(0.709–2.932)</td><td rowspan="1" colspan="1">0.312</td><td rowspan="1" colspan="1">0.0444</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">PPARG</italic></td><td rowspan="1" colspan="1">rs1801282</td><td rowspan="1" colspan="1">C</td><td rowspan="1" colspan="1">1.650(0.998–2.726)</td><td rowspan="1" colspan="1">0.051</td><td rowspan="1" colspan="1">0.0056</td></tr></tbody></table><table-wrap-foot><fn id="tfn0003"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="positive">: Odd ratios and P-values were adjusted for age, sex, BMI, SBP; DBP; TG; FBG; Smoke and Drink under the additive model.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
        <p><citation_analysis attribute="neither">The PRS was independently associated with linear increases in AHI (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0003" ref-type="table">Table 3</xref></citation_analysis><citation_analysis attribute="neither">). An increase of 1 SD of the PRS was associated with an increase of 1.24 times/h (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.046) in AHI. Higher PRS was associated with higher AHI. The medians and 75th percentiles of AHI increased significantly from lower PRS to higher PRS (</citation_analysis><citation_analysis attribute="positive"><xref rid="f0001" ref-type="fig">Figure 1</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0003"><label>Table 3</label><caption><p><citation_analysis attribute="neither">Association of the PRS with AHI and OSA</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">PRS Category</th><th colspan="2" align="center" rowspan="1">AHI</th><th colspan="2" align="center" rowspan="1">OSA</th><th colspan="2" rowspan="1">Moderate-to-Severe OSA</th></tr><tr><th rowspan="1" colspan="1">β (95% CI)</th><th rowspan="1" colspan="1">P value</th><th rowspan="1" colspan="1">OR (95% CI)</th><th rowspan="1" colspan="1">P value</th><th rowspan="1" colspan="1">OR (95% CI)</th><th rowspan="1" colspan="1">P value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Low risk</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Intermediate risk</td><td rowspan="1" colspan="1">5.349 (−0.094–10.791)</td><td rowspan="1" colspan="1">0.054</td><td rowspan="1" colspan="1">2.256(1.110–4.587)</td><td rowspan="1" colspan="1">0.025</td><td rowspan="1" colspan="1">4.241(1.848–9.733)</td><td rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="1" colspan="1">High risk</td><td rowspan="1" colspan="1">7.001(1.504–12.499) 0.013</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2.841(1.374–5.874)</td><td rowspan="1" colspan="1">0.005</td><td rowspan="1" colspan="1">5.372(2.299–12.551)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Per SD</td><td rowspan="1" colspan="1">1.241 (0.025–2.457)</td><td rowspan="1" colspan="1">0.046</td><td rowspan="1" colspan="1">1.237(1.021–1.499)</td><td rowspan="1" colspan="1">0.030</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="tfn0004"><p><citation_analysis attribute="positive"><bold>Notes</bold></citation_analysis><citation_analysis attribute="positive">: Risk estimates were adjusted for age, sex, BMI, SBP; DBP; TG; FBG; Smoke; Drink. PRS was constructed by summing the number of risk alleles among 9 SNPs shown in </citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="negative">. PRS risk boundaries: low &lt;2 (≤20th percentile); intermediate ≥2 and&lt;7 (20th–80th percentile); high ≥7 (≥80th percentile).</citation_analysis></p></fn><fn id="tfn0005"><p><citation_analysis attribute="positive"><bold>Abbreviations</bold></citation_analysis><citation_analysis attribute="negative">: OR, odd ratio; CI, confidence interval; PRS, polygenic risk score.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><fig position="float" id="f0001" fig-type="figure"><label>Figure 1</label><caption><p><citation_analysis attribute="neither">Association of PRS with AHI.</citation_analysis></p></caption><graphic xlink:href="NSS-14-363-g0001" content-type="print-only" position="float"/></fig></citation_analysis></p>
        <p><citation_analysis attribute="negative">To investigate whether increasing the number of risk alleles can increase the occurrence of OSA, we first developed a genetic risk score based on the nine SNPs. The total number of risk alleles in all subjects analyzed in the study ranged from 0 to 15. A higher PRS was significantly associated with an increased risk of OSA, independent of established clinical predictors, including age, sex, BMI, blood pressure, TG, FPG, smoking status, and drinking status (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0003" ref-type="table">Table 3</xref></citation_analysis><citation_analysis attribute="neither">). An increase of 1 SD of the PRS was associated with a 24% increase in the odds of incident OSA (OR: 1.237; 95% CI: 1.021–1.499, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="negative"> = 0.03). Specifically, when evaluating participants in low, intermediate, and high genetic risk score categories, a gradient of risk for having OSA was evident. Those with higher PRS had a 2.84-fold (95% CI: 1.374–5.874, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.005) and 5.37-fold (95% CI: 2.299–12.551, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="negative"> &lt; 0.001) greater risk for OSA and moderate-to-severe OSA than those with lower genetic risk, respectively.</citation_analysis></p>
      </sec>
      <sec id="s0003-s2003">
        <title>Assessment of the PRS</title>
        <p><citation_analysis attribute="negative">From our univariate and multivariate logistic regression analysis, we identified four independent risk factors for OSA: age (OR = 1.043, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001), male gender (OR = 3.490, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> &lt; 0.001), BMI (OR = 1.293, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="negative"> &lt; 0.001), and high risk in the BQ (OR = 2.085, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.004). These factors were all significantly associated with OSA (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0004" ref-type="table">Table 4</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><table-wrap position="float" id="t0004"><label>Table 4</label><caption><p><citation_analysis attribute="neither">Univariable and Multivariable Logistic Regression Analysis for OSA</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Characteristics</th><th colspan="2" align="center" rowspan="1">Univariable Analysis</th><th colspan="2" align="center" rowspan="1">Multivariable Analysis</th></tr><tr><th rowspan="1" colspan="1">OR (95% CI)</th><th rowspan="1" colspan="1">P value</th><th rowspan="1" colspan="1">OR (95% CI)</th><th rowspan="1" colspan="1">P value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Sex Female</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Male</td><td rowspan="1" colspan="1">2.6 (1.8–3.8)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">3.490 (2.098–5.806)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Age</td><td rowspan="1" colspan="1">1.0 (1.0–1.0)</td><td rowspan="1" colspan="1">0.027</td><td rowspan="1" colspan="1">1.043 (1.025–1.061)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">BMI</td><td rowspan="1" colspan="1">1.3 (1.2–1.3)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">1.293 (1.219–1.371)</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">SBP</td><td rowspan="1" colspan="1">1.0 (1.0–1.0)</td><td rowspan="1" colspan="1">0.005</td><td rowspan="1" colspan="1">0.999 (0.985–1.012)</td><td rowspan="1" colspan="1">0.864</td></tr><tr><td rowspan="1" colspan="1">DBP</td><td rowspan="1" colspan="1">1.0 (1.0–1.0)</td><td rowspan="1" colspan="1">0.004</td><td rowspan="1" colspan="1">1.007 (0.987–1.027)</td><td rowspan="1" colspan="1">0.492</td></tr><tr><td rowspan="1" colspan="1">HDL-C</td><td rowspan="1" colspan="1">0.9 (0.8–1.2)</td><td rowspan="1" colspan="1">0.586</td><td rowspan="1" colspan="1">1.325 (0.831–2.112)</td><td rowspan="1" colspan="1">0.237</td></tr><tr><td rowspan="1" colspan="1">LDL-C</td><td rowspan="1" colspan="1">1.0 (0.8–1.2)</td><td rowspan="1" colspan="1">0.928</td><td rowspan="1" colspan="1">0.885 (0.641–1.222)</td><td rowspan="1" colspan="1">0.458</td></tr><tr><td rowspan="1" colspan="1">TC</td><td rowspan="1" colspan="1">1.0 (0.9–1.2)</td><td rowspan="1" colspan="1">0.530</td><td rowspan="1" colspan="1">1.127 (0.861–1.476)</td><td rowspan="1" colspan="1">0.383</td></tr><tr><td rowspan="1" colspan="1">TG</td><td rowspan="1" colspan="1">1.3 (1.1–1.6)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">1.170 (0.990–1.382)</td><td rowspan="1" colspan="1">0.065</td></tr><tr><td rowspan="1" colspan="1">FBG</td><td rowspan="1" colspan="1">1.1 (1.0–1.2)</td><td rowspan="1" colspan="1">0.003</td><td rowspan="1" colspan="1">1.088 (0.993–1.192)</td><td rowspan="1" colspan="1">0.071</td></tr><tr><td rowspan="1" colspan="1">Drink</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Yes</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> No</td><td rowspan="1" colspan="1">1.2 (0.8–1.6)</td><td rowspan="1" colspan="1">0.342</td><td rowspan="1" colspan="1">0.807 (0.533–1.221)</td><td rowspan="1" colspan="1">0.311</td></tr><tr><td rowspan="1" colspan="1">Smoke</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Yes</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> No</td><td rowspan="1" colspan="1">1.4 (1.0–1.9)</td><td rowspan="1" colspan="1">0.066</td><td rowspan="1" colspan="1">1.040 (0.685–1.579)</td><td rowspan="1" colspan="1">0.854</td></tr><tr><td rowspan="1" colspan="1">ESS</td><td rowspan="1" colspan="1">1.1 (1.0–1.1)</td><td rowspan="1" colspan="1">0.007</td><td rowspan="1" colspan="1">0.996 (0.952–1.043)</td><td rowspan="1" colspan="1">0.866</td></tr><tr><td rowspan="1" colspan="1">Berlin Questionnaire</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Low risk</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> High risk</td><td rowspan="1" colspan="1">3.4 (2.3–5.2)</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">2.085 (1.266–3.436)</td><td rowspan="1" colspan="1">0.004</td></tr></tbody></table></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
        <p><citation_analysis attribute="negative">To predict disease status for OSA in a given individual, we constructed a prediction model on the basis of the PRS or the liability value calculated from PRS, as well as clinical risk factors. </citation_analysis><citation_analysis attribute="positive"><xref rid="f0002" ref-type="fig">Figure 2</xref></citation_analysis><citation_analysis attribute="negative"> shows the ROC for OSA. In model 1, the conventional risk factors of age, sex, BMI, and BQ were included. The AUC for the conventional model was 0.75. Incorporating PRS into the model statistically significantly increased the AUC to 0.78 (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.024). In moderate-to-severe OSA subjects, adding the PRS into model 1 increased the AUC from 0.80 to 0.83 (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">P</italic></citation_analysis><citation_analysis attribute="neither"> = 0.017).</citation_analysis><citation_analysis attribute="positive"><fig position="float" id="f0002" fig-type="figure"><label>Figure 2</label><caption><p><citation_analysis attribute="negative">ROC curves for the prediction model on the basis of the number of risk alleles for OSA. (</citation_analysis><citation_analysis attribute="positive"><bold>A</bold></citation_analysis><citation_analysis attribute="neither">) All OSA and (</citation_analysis><citation_analysis attribute="positive"><bold>B</bold></citation_analysis><citation_analysis attribute="positive">) restricted to moderate-to-severe OSA. The prediction model for OSA was constructed using the logistic regression model, and ROC curves for the model were generated. In model 1, only clinical risk factors (age, sex, BMI and Berlin questionnaire) were included, whereas the number of risk alleles was used as an independent variable together with age, sex, BMI and Berlin questionnaire as covariates in model 2.</citation_analysis></p></caption><graphic xlink:href="NSS-14-363-g0002" content-type="print-only" position="float"/></fig></citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0004">
      <title>Discussion</title>
      <p><citation_analysis attribute="negative">OSA is a heritable polygenic disease. Obesity, craniofacial structure, neural control of upper airway muscles, and sleep and circadian rhythm are risk factors for OSA. Genes related to these factors contribute to the genetic spectrum of OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0016" ref-type="bibr">16</xref></citation_analysis><citation_analysis attribute="negative"> Obesity is an independent risk factor for OSA, which increases the risk of OSA by 10–14 times. Obesity, measured by BMI, is expected to explain up to 40% of genetic variation in AHI.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0017" ref-type="bibr">17</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive"><italic toggle="yes">ADIPOQ, TNF</italic></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">PPARG</italic></citation_analysis><citation_analysis attribute="negative"> play very important roles in the process of lipid metabolism and obesity. They participate in the body’s fat metabolism and body energy balance by affecting the expression of transcription factors in glucose metabolism, lipid metabolism, and adipocyte differentiation. They may increase the risk of OSA by increasing the risk of obesity. Previous studies found that all three genes, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">ADIPOQ, TNF</italic></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">PPARG</italic></citation_analysis><citation_analysis attribute="neither">, are associated with OSA. Importantly, the levels of circulating adiponectin were significantly different in patients with OSA compared with those in control subjects.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18–20</xref></citation_analysis><citation_analysis attribute="neither"> Common variations in the </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">ADIPOQ</italic></citation_analysis><citation_analysis attribute="negative"> gene were linked to an increased risk and severity of OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0021" ref-type="bibr">21</xref></citation_analysis><citation_analysis attribute="neither"> The </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">ADIPOQ</italic></citation_analysis><citation_analysis attribute="neither"> gene encodes the hormone adiponectin, and its levels correlate negatively with BMI.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0022" ref-type="bibr">22</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0023" ref-type="bibr">23</xref></citation_analysis><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">TNF</italic></citation_analysis><citation_analysis attribute="neither">-α gene expression levels were significantly higher in the OSA group than in the control group.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0024" ref-type="bibr">24</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0025" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="positive"> Some studies suggested a relationship between polymorphic variation in the </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">TNF</italic></citation_analysis><citation_analysis attribute="neither">-α gene and OSA. The −308G/A polymorphism has been associated with increased levels of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">TNF</italic></citation_analysis><citation_analysis attribute="neither">-α, which is involved in intermittent hypoxia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0025" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0026" ref-type="bibr">26</xref></citation_analysis><citation_analysis attribute="neither"> Meta-analysis of three studies estimated that the </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">TNF</italic></citation_analysis><citation_analysis attribute="negative">-α (−308G/A) polymorphism is a risk factor for OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0027" ref-type="bibr">27</xref></citation_analysis><citation_analysis attribute="positive"> A limitation of our study is that we did not include this SNP in our analysis. A previous study reported that the expression of </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">PPARG</italic></citation_analysis><citation_analysis attribute="neither"> was downregulated in the adipose tissue of OSA patients compared with controls.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0028" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="neither"> Furthermore, </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">PPARG</italic></citation_analysis><citation_analysis attribute="neither"> was positively correlated with the BMI and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">PPARG</italic></citation_analysis><citation_analysis attribute="positive"> (rs1801282) with the allelic variants of Ala12Ala or Pro12Pro will most likely become overweight/obese.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0029" ref-type="bibr">29</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0030" ref-type="bibr">30</xref></citation_analysis><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">PPARG</italic></citation_analysis><citation_analysis attribute="neither"> can lead to obesity by increasing fatty acid absorption and fat accumulation. Consistent with those results, our previous research also found that </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">ADIPOQ, TNF</italic></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">PPARG</italic></citation_analysis><citation_analysis attribute="neither"> were associated with OSA risk. </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">ADIPOQ</italic></citation_analysis><citation_analysis attribute="neither"> variants rs3774262, rs4686803, rs1063537, and rs2082940 and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">PPARG</italic></citation_analysis><citation_analysis attribute="neither"> rs1801282 were associated with the prevalence of OSA in Han Chinese individuals.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0010" ref-type="bibr">10</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0011" ref-type="bibr">11</xref></citation_analysis><citation_analysis attribute="neither"> The </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">TNF</italic></citation_analysis><citation_analysis attribute="positive"> gene variants rs3093661, rs3093662, and rs3093664 were also associated with risk of OSA in the same dataset. Because of the importance of obesity in OSA, we therefore included these recently identified common variants of the </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">PPARG, TNF</italic></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">ADIPOQ</italic></citation_analysis><citation_analysis attribute="neither"> genes in this study, establishing a PRS and exploring the genetic architecture of OSA.</citation_analysis></p>
      <p><citation_analysis attribute="positive">Recent studies have demonstrated the utility of PRS for disease risk stratification, as well as their implications for early disease detection, prevention, therapeutic intervention, and/or life planning.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0031" ref-type="bibr">31</xref></citation_analysis><citation_analysis attribute="positive"> This is a robust approach in that it provides valuable information on the additive effects of multiple gene variants in the same individual. It has been used for risk scoring of many polygenic diseases, including cardiovascular disease, diabetes, and breast cancer, as well as neurological disorders.</citation_analysis></p>
      <p><citation_analysis attribute="neither">In our study, we used the PRS approach to determine OSA susceptibility. We selected nine variants from adipokine-pathway genes (</citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">TNF, PPARG</italic></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><italic toggle="yes">ADIPOQ</italic></citation_analysis><citation_analysis attribute="positive">), meaning that an individual could have a maximum of 18 risk alleles. By using a gene scoring approach, we found that SNPs in adipokine pathway genes may influence the development of OSA. Subjects with a higher PRS had a 2.84-fold greater risk of OSA than those with a lower genetic risk. Furthermore, this inclusive risk score provides significant improvement in the discrimination and prediction of OSA. The AUC increased significantly from 0.75 to 0.78 for OSA when genetic variants were combined with clinical risk factors. The AUC increased to 0.83 in Model 2, meaning that the PRS had a greater predictive effect on moderate-to-severe OSA. While the AUC of the PRS alone may appear modest, the predicted risk differences in the tails of the distribution are large.</citation_analysis></p>
      <p><citation_analysis attribute="positive">Our results should be interpreted in the context of several potential limitations. Firstly, we performed the present association study in a cross-sectional setting; therefore, it is difficult to estimate the accurate predictive power of our genetic model. Secondly, there are many environmental factors affecting OSA, and this study only explores four common factors: gender, age, BMI, and BQ. Thirdly, we took a focused candidate gene approach to evaluate key SNPs, excluding additional genes that may contribute to OSA. Several reported OSA risk-associated SNPs from genome-wide association studies were not included in our study. Our study also has several strengths: i) it was large enough for key outcomes of interest, ii) we used statistical strategies to assess the robustness of associations, such as bootstrap resampling and discrimination improvement measures; and iii) subjects in this study were consecutively recruited to reduce the effects of outcome-selection bias.</citation_analysis></p>
    </sec>
    <sec id="s0005">
      <title>Conclusion</title>
      <p><citation_analysis attribute="positive">In conclusion, the PRS we constructed here was significantly associated with an increased risk of OSA in a Chinese Han population. Furthermore, combining this PRS with conventional risk factors for OSA could improve the predictive performance. Although currently available genetic information remains insufficient for an accurate prediction of OSA, the information may be useful in groups with a particular clinical background, such as the obese population. Future work is necessary to identify the underlying functional or causal gene variants with potentially stronger effects, and updated analysis using these genes may further improve risk determination for OSA.</citation_analysis></p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p><citation_analysis attribute="neither">We thank all study participants and investigators for making this project possible. We thank Xiaolu Jiao, Yunyun Yang, and Huahui Yu for their assistance in data acquisition and analysis. We also thank Shaoping Nie, Ming Zhang, Wenli Cheng, and Jingyao Fan for their assistance in blood sample collection. Dr. Wei Yongxiang and Dr. Qin Yanwen contributed to designing the research plan and revising the manuscript. Their research interests include obstructive sleep apnea epidemiology, the genetics of obstructive sleep apnea, and obstructive sleep apnea-associated cardiovascular diseases. We thank J. Iacona, Ph.D., from Liwen Bianji (Edanz) for editing the English text of a draft of this manuscript.</citation_analysis></p>
    </ack>
    <sec id="s0006">
      <title>Data Sharing Statement</title>
      <p><citation_analysis attribute="neither">All the data from this manuscript are publicly available.</citation_analysis></p>
    </sec>
    <sec id="s0007">
      <title>Ethics Approval and Consent to Participate</title>
      <p><citation_analysis attribute="positive">All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All participants provided informed consent.</citation_analysis></p>
    </sec>
    <sec id="s0008">
      <title>Consent for Publication</title>
      <p><citation_analysis attribute="neither">All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.</citation_analysis></p>
    </sec>
    <sec id="s0009">
      <title>Author Contributions</title>
      <p><citation_analysis attribute="positive">All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.</citation_analysis></p>
    </sec>
    <sec sec-type="COI-statement" id="s0010">
      <title>Disclosure</title>
      <p><citation_analysis attribute="neither">The authors declare that they have no conflicts of interest.</citation_analysis></p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="cit0001">
        <label>1.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Loube</surname>
<given-names>DI</given-names></string-name>, <string-name><surname>Gay</surname>
<given-names>PC</given-names></string-name>, <string-name><surname>Strohl</surname>
<given-names>KP</given-names></string-name>, <string-name><surname>Pack</surname>
<given-names>AI</given-names></string-name>, <string-name><surname>White</surname>
<given-names>DP</given-names></string-name>, <string-name><surname>Collop</surname>
<given-names>NA</given-names></string-name>. <article-title>Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: a consensus statement</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>1999</year>;<volume>115</volume>(<issue>3</issue>):<fpage>863</fpage>–<lpage>866</lpage>. doi:<pub-id pub-id-type="doi">10.1378/chest.115.3.863</pub-id><pub-id pub-id-type="pmid">10084504</pub-id></mixed-citation>
      </ref>
      <ref id="cit0002">
        <label>2.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Cade</surname>
<given-names>BE</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Stilp</surname>
<given-names>AM</given-names></string-name>, et al. <article-title>Genetic associations with obstructive sleep apnea traits in Hispanic/Latino Americans</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2016</year>;<volume>194</volume>(<issue>7</issue>):<fpage>886</fpage>–<lpage>897</lpage>. doi:<pub-id pub-id-type="doi">10.1164/rccm.201512-2431OC</pub-id><pub-id pub-id-type="pmid">26977737</pub-id></mixed-citation>
      </ref>
      <ref id="cit0003">
        <label>3.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Peppard</surname>
<given-names>PE</given-names></string-name>, <string-name><surname>Young</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Barnet</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Palta</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hagen</surname>
<given-names>EW</given-names></string-name>, <string-name><surname>Hla</surname>
<given-names>KM</given-names></string-name>. <article-title>Increased prevalence of sleep-disordered breathing in adults</article-title>. <source><italic toggle="yes">Am J Epidemiol</italic></source>. <year>2013</year>;<volume>177</volume>(<issue>9</issue>):<fpage>1006</fpage>–<lpage>1014</lpage>. doi:<pub-id pub-id-type="doi">10.1093/aje/kws342</pub-id><pub-id pub-id-type="pmid">23589584</pub-id></mixed-citation>
      </ref>
      <ref id="cit0004">
        <label>4.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Peng</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Song</surname>
<given-names>J</given-names></string-name>. <article-title>Effects of CPAP on the transcriptional signatures in patients with obstructive sleep apnea via coexpression network analysis</article-title>. <source><italic toggle="yes">J Cell Biochem</italic></source>. <year>2019</year>;<volume>120</volume>(<issue>6</issue>):<fpage>9277</fpage>–<lpage>9290</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jcb.28203</pub-id><pub-id pub-id-type="pmid">30719767</pub-id></mixed-citation>
      </ref>
      <ref id="cit0005">
        <label>5.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kripke</surname>
<given-names>DF</given-names></string-name>, <string-name><surname>Kline</surname>
<given-names>LE</given-names></string-name>, <string-name><surname>Nievergelt</surname>
<given-names>CM</given-names></string-name>, et al. <article-title>Genetic variants associated with sleep disorders</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2015</year>;<volume>16</volume>(<issue>2</issue>):<fpage>217</fpage>–<lpage>224</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2014.11.003</pub-id><pub-id pub-id-type="pmid">25660813</pub-id></mixed-citation>
      </ref>
      <ref id="cit0006">
        <label>6.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Varvarigou</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Dahabreh</surname>
<given-names>IJ</given-names></string-name>, <string-name><surname>Malhotra</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kales</surname>
<given-names>SN</given-names></string-name>. <article-title>A review of genetic association studies of obstructive sleep apnea: field synopsis and meta-analysis</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2011</year>;<volume>34</volume>(<issue>11</issue>):<fpage>1461</fpage>–<lpage>1468</lpage>. doi:<pub-id pub-id-type="doi">10.5665/sleep.1376</pub-id><pub-id pub-id-type="pmid">22043116</pub-id></mixed-citation>
      </ref>
      <ref id="cit0007">
        <label>7.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhao</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Qian</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Abdominal obesity is more strongly correlated with obstructive sleep apnea than general obesity in China: results from two separated observational and longitudinal studies</article-title>. <source><italic toggle="yes">Obes Surg</italic></source>. <year>2019</year>;<volume>29</volume>(<issue>8</issue>):<fpage>2535</fpage>–<lpage>2547</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11695-019-03870-z</pub-id><pub-id pub-id-type="pmid">31111342</pub-id></mixed-citation>
      </ref>
      <ref id="cit0008">
        <label>8.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Pang</surname>
<given-names>XL</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>R</given-names></string-name>. <article-title>Adiponectin, omentin, ghrelin, and visfatin levels in obese patients with severe obstructive sleep apnea</article-title>. <source><italic toggle="yes">Biomed Res Int</italic></source>. <year>2018</year>;<volume>2018</volume>:<fpage>3410135</fpage>. doi:<pub-id pub-id-type="doi">10.1155/2018/3410135</pub-id><pub-id pub-id-type="pmid">30151379</pub-id></mixed-citation>
      </ref>
      <ref id="cit0009">
        <label>9.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Van Eyck</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Van Hoorenbeeck</surname>
<given-names>K</given-names></string-name>, <string-name><surname>De Winter</surname>
<given-names>BY</given-names></string-name>, <string-name><surname>Van Gaal</surname>
<given-names>L</given-names></string-name>, <string-name><surname>De Backer</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Verhulst</surname>
<given-names>SL</given-names></string-name>. <article-title>Sleep-disordered breathing, systemic adipokine secretion, and metabolic dysregulation in overweight and obese children and adolescents</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2017</year>;<volume>30</volume>:<fpage>52</fpage>–<lpage>56</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2015.11.014</pub-id><pub-id pub-id-type="pmid">28215263</pub-id></mixed-citation>
      </ref>
      <ref id="cit0010">
        <label>10.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Yang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Jiao</surname>
<given-names>X</given-names></string-name>, et al. <article-title>Targeted sequencing analysis of the adiponectin gene identifies variants associated with obstructive sleep apnoea in Chinese Han population</article-title>. <source><italic toggle="yes">Medicine</italic></source>. <year>2019</year>;<volume>98</volume>(<issue>16</issue>):<fpage>e15219</fpage>. doi:<pub-id pub-id-type="doi">10.1097/MD.0000000000015219</pub-id><pub-id pub-id-type="pmid">31008949</pub-id></mixed-citation>
      </ref>
      <ref id="cit0011">
        <label>11.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jiao</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Targeted sequencing analysis of PPARG identifies a risk variant associated with obstructive sleep apnea in Chinese Han subjects</article-title>. <source><italic toggle="yes">Sleep Breath</italic></source>. <year>2020</year>;<volume>24</volume>:<fpage>167</fpage>–<lpage>174</lpage>.<pub-id pub-id-type="pmid">31044373</pub-id></mixed-citation>
      </ref>
      <ref id="cit0012">
        <label>12.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Juan</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Jiao</surname>
<given-names>X</given-names></string-name>, et al. <article-title>Targeted sequencing analysis of the leptin receptor gene identifies variants associated with obstructive sleep apnoea in Chinese Han Population</article-title>. <source><italic toggle="yes">Lung</italic></source>. <year>2019</year>;<volume>197</volume>(<issue>5</issue>):<fpage>577</fpage>–<lpage>584</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00408-019-00254-z</pub-id><pub-id pub-id-type="pmid">31372721</pub-id></mixed-citation>
      </ref>
      <ref id="cit0013">
        <label>13.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Berry</surname>
<given-names>RB</given-names></string-name>, <string-name><surname>Budhiraja</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Gottlieb</surname>
<given-names>DJ</given-names></string-name>, et al. <article-title>Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the sleep apnea definitions task force of the American academy of sleep medicine</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2012</year>;<volume>8</volume>(<issue>5</issue>):<fpage>597</fpage>–<lpage>619</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.2172</pub-id><pub-id pub-id-type="pmid">23066376</pub-id></mixed-citation>
      </ref>
      <ref id="cit0014">
        <label>14.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Netzer</surname>
<given-names>NC</given-names></string-name>, <string-name><surname>Stoohs</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Netzer</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Clark</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Strohl</surname>
<given-names>KP</given-names></string-name>. <article-title>Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome</article-title>. <source><italic toggle="yes">Ann Intern Med</italic></source>. <year>1999</year>;<volume>131</volume>(<issue>7</issue>):<fpage>485</fpage>–<lpage>491</lpage>. doi:<pub-id pub-id-type="doi">10.7326/0003-4819-131-7-199910050-00002</pub-id><pub-id pub-id-type="pmid">10507956</pub-id></mixed-citation>
      </ref>
      <ref id="cit0015">
        <label>15.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhou</surname>
<given-names>BF</given-names></string-name>. <article-title>Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases–report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults</article-title>. <source><italic toggle="yes">Biomed Environ Sci</italic></source>. <year>2002</year>;<volume>15</volume>(<issue>3</issue>):<fpage>245</fpage>–<lpage>252</lpage>.<pub-id pub-id-type="pmid">12500665</pub-id></mixed-citation>
      </ref>
      <ref id="cit0016">
        <label>16.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mukherjee</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Saxena</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Palmer</surname>
<given-names>LJ</given-names></string-name>. <article-title>The genetics of obstructive sleep apnoea</article-title>. <source><italic toggle="yes">Respirology</italic></source>. <year>2018</year>;<volume>23</volume>(<issue>1</issue>):<fpage>18</fpage>–<lpage>27</lpage>. doi:<pub-id pub-id-type="doi">10.1111/resp.13212</pub-id><pub-id pub-id-type="pmid">29113020</pub-id></mixed-citation>
      </ref>
      <ref id="cit0017">
        <label>17.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Patel</surname>
<given-names>SR</given-names></string-name>, <string-name><surname>Larkin</surname>
<given-names>EK</given-names></string-name>, <string-name><surname>Redline</surname>
<given-names>S</given-names></string-name>. <article-title>Shared genetic basis for obstructive sleep apnea and adiposity measures</article-title>. <source><italic toggle="yes">Int J Obesity</italic></source>. <year>2008</year>;<volume>32</volume>(<issue>5</issue>):<fpage>795</fpage>–<lpage>800</lpage>. doi:<pub-id pub-id-type="doi">10.1038/sj.ijo.0803803</pub-id></mixed-citation>
      </ref>
      <ref id="cit0018">
        <label>18.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sertogullarindan</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Komuroglu</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ucler</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Gunbatar</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Sunnetcioglu</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Cokluk</surname>
<given-names>E</given-names></string-name>. <article-title>Betatrophin association with serum triglyceride levels in obstructive sleep apnea patients</article-title>. <source><italic toggle="yes">Ann Thorac Med</italic></source>. <year>2019</year>;<volume>14</volume>(<issue>1</issue>):<fpage>63</fpage>–<lpage>68</lpage>. doi:<pub-id pub-id-type="doi">10.4103/atm.ATM_52_18</pub-id><pub-id pub-id-type="pmid">30745937</pub-id></mixed-citation>
      </ref>
      <ref id="cit0019">
        <label>19.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zeng</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Hu</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>L</given-names></string-name>. <article-title>Association of adiponectin level and obstructive sleep apnea prevalence in obese subjects</article-title>. <source><italic toggle="yes">Medicine</italic></source>. <year>2017</year>;<volume>96</volume>(<issue>32</issue>):<fpage>e7784</fpage>. doi:<pub-id pub-id-type="doi">10.1097/MD.0000000000007784</pub-id><pub-id pub-id-type="pmid">28796077</pub-id></mixed-citation>
      </ref>
      <ref id="cit0020">
        <label>20.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gonzalez</surname>
<given-names>FJ</given-names></string-name>, <string-name><surname>Xie</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>C</given-names></string-name>. <article-title>The role of hypoxia-inducible factors in metabolic diseases</article-title>. <source><italic toggle="yes">Nat Rev Endocrinol</italic></source>. <year>2019</year>;<volume>15</volume>(<issue>1</issue>):<fpage>21</fpage>–<lpage>32</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41574-018-0096-z</pub-id></mixed-citation>
      </ref>
      <ref id="cit0021">
        <label>21.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wu</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>T</given-names></string-name>, et al. <article-title>Single nucleotide polymorphisms in adiponectin gene are not directly associated with increased risk of obstructive sleep apnea syndrome in a Chinese Han Population</article-title>. <source><italic toggle="yes">ORL J Otorhinolaryngol Relat Spec</italic></source>. <year>2016</year>;<volume>78</volume>(<issue>6</issue>):<fpage>308</fpage>–<lpage>319</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000454734</pub-id><pub-id pub-id-type="pmid">28068661</pub-id></mixed-citation>
      </ref>
      <ref id="cit0022">
        <label>22.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kanu</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Gu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zhi</surname>
<given-names>S</given-names></string-name>. <article-title>Single nucleotide polymorphism rs3774261 in the AdipoQ gene is associated with the risk of coronary heart disease (CHD) in Northeast Han Chinese population: a case-control study</article-title>. <source><italic toggle="yes">Lipids Health Dis</italic></source>. <year>2016</year>;<volume>15</volume>(<issue>1</issue>):<fpage>6</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12944-015-0173-4</pub-id><pub-id pub-id-type="pmid">26754433</pub-id></mixed-citation>
      </ref>
      <ref id="cit0023">
        <label>23.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Du</surname>
<given-names>SX</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>LL</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Dong</surname>
<given-names>QJ</given-names></string-name>, <string-name><surname>Xuan</surname>
<given-names>SY</given-names></string-name>, <string-name><surname>Xin</surname>
<given-names>YN</given-names></string-name>. <article-title>Association of adiponectin gene polymorphisms with the risk of coronary artery disease in patients with nonalcoholic fatty liver disease in a Chinese Han Population</article-title>. <source><italic toggle="yes">Hepat Mon</italic></source>. <year>2016</year>;<volume>16</volume>(<issue>7</issue>):<fpage>e37388</fpage>. doi:<pub-id pub-id-type="doi">10.5812/hepatmon.37388</pub-id><pub-id pub-id-type="pmid">27642347</pub-id></mixed-citation>
      </ref>
      <ref id="cit0024">
        <label>24.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ugur</surname>
<given-names>KS</given-names></string-name>, <string-name><surname>Acar</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ozol</surname>
<given-names>D</given-names></string-name>, et al. <article-title>Gene expression profiles of tumor necrosis factor-alpha and endothelin-1 in obstructive sleep apnea</article-title>. <source><italic toggle="yes">ORL J Otorhinolaryngol Relat Spec</italic></source>. <year>2019</year>;<volume>81</volume>(<issue>1</issue>):<fpage>16</fpage>–<lpage>23</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000490353</pub-id><pub-id pub-id-type="pmid">30537754</pub-id></mixed-citation>
      </ref>
      <ref id="cit0025">
        <label>25.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bhushan</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Guleria</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Misra</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Luthra</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Vikram</surname>
<given-names>NK</given-names></string-name>. <article-title>TNF-alpha gene polymorphism and TNF-alpha levels in obese Asian Indians with obstructive sleep apnea</article-title>. <source><italic toggle="yes">Respir Med</italic></source>. <year>2009</year>;<volume>103</volume>(<issue>3</issue>):<fpage>386</fpage>–<lpage>392</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.rmed.2008.10.001</pub-id><pub-id pub-id-type="pmid">19022640</pub-id></mixed-citation>
      </ref>
      <ref id="cit0026">
        <label>26.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Riha</surname>
<given-names>RL</given-names></string-name>, <string-name><surname>Brander</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Vennelle</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Tumour necrosis factor-alpha (−308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome</article-title>. <source><italic toggle="yes">Eur Respir J</italic></source>. <year>2005</year>;<volume>26</volume>(<issue>4</issue>):<fpage>673</fpage>–<lpage>678</lpage>. doi:<pub-id pub-id-type="doi">10.1183/09031936.05.00130804</pub-id><pub-id pub-id-type="pmid">16204600</pub-id></mixed-citation>
      </ref>
      <ref id="cit0027">
        <label>27.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zhong</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Xiong</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Shi</surname>
<given-names>M</given-names></string-name>. <article-title>An updated meta-analysis of the association between tumor necrosis factor-alpha −308G/A polymorphism and obstructive sleep apnea-hypopnea syndrome</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2014</year>;<volume>9</volume>(<issue>9</issue>):<fpage>e106270</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0106270</pub-id><pub-id pub-id-type="pmid">25222485</pub-id></mixed-citation>
      </ref>
      <ref id="cit0028">
        <label>28.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gharib</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Hayes</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Rosen</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Patel</surname>
<given-names>SR</given-names></string-name>. <article-title>A pathway-based analysis on the effects of obstructive sleep apnea in modulating visceral fat transcriptome</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2013</year>;<volume>36</volume>(<issue>1</issue>):<fpage>23</fpage>–<lpage>30</lpage>. doi:<pub-id pub-id-type="doi">10.5665/sleep.2294</pub-id><pub-id pub-id-type="pmid">23288968</pub-id></mixed-citation>
      </ref>
      <ref id="cit0029">
        <label>29.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Castellano-Castillo</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Denechaud</surname>
<given-names>P-D</given-names></string-name>, <string-name><surname>Fajas</surname>
<given-names>L</given-names></string-name>. <article-title>Human adipose tissue H3K4me3 histone mark in adipogenic, lipid metabolism and inflammatory genes is positively associated with BMI and HOMA-IR</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2019</year>;<volume>14</volume>(<issue>4</issue>):<fpage>e0215083</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0215083</pub-id><pub-id pub-id-type="pmid">30958852</pub-id></mixed-citation>
      </ref>
      <ref id="cit0030">
        <label>30.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Rodríguez-Pardo</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Segura</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Zamorano-León</surname>
<given-names>JJ</given-names></string-name>. <article-title>Decision tree learning to predict overweight/obesity based on body mass index and gene polymporphisms</article-title>. <source><italic toggle="yes">Gene</italic></source>. <year>2019</year>;<volume>699</volume>:<fpage>88</fpage>–<lpage>93</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.gene.2019.03.011</pub-id><pub-id pub-id-type="pmid">30858138</pub-id></mixed-citation>
      </ref>
      <ref id="cit0031">
        <label>31.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Torkamani</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Wineinger</surname>
<given-names>NE</given-names></string-name>, <string-name><surname>Topol</surname>
<given-names>EJ</given-names></string-name>. <article-title>The personal and clinical utility of polygenic risk scores</article-title>. <source><italic toggle="yes">Nat Rev Genet</italic></source>. <year>2018</year>;<volume>19</volume>(<issue>9</issue>):<fpage>581</fpage>–<lpage>590</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41576-018-0018-x</pub-id><pub-id pub-id-type="pmid">29789686</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
